OSG heads into its Q1 2026 earnings call on May 7 having just delivered a blowout result, yet the stock has given back ground over the past week — a tension that makes the call itself the event to watch.
Octave Specialty Group reported after the close on May 6, posting adjusted EPS of $0.37 against a consensus of $0.01 and revenue of $104.2M against expectations of $64.8M. Both were decisive beats. The EPS surprise factor score ranks at the 98th percentile of the ORTEX universe — not a one-off fluke, but a pattern. The stock closed at $4.38 on May 5, up 3.3% on the day, yet still off 4.2% for the week and 5.2% for the month, leaving bulls having to argue that the stock has not priced in what the numbers just delivered.
The most interesting signal heading into the print was in options, and it told a bullish story. The put/call ratio dropped to 0.205 on May 5 — well below its 20-day average of 0.284, and roughly 2.3 standard deviations below that mean. That is the most call-heavy positioning seen for months, close to the 52-week low of 0.035. Options traders were not hedging into earnings; they were leaning on the upside. The prior session's reading of 0.304 underscored just how sharp the shift was in a single day, with buyers piling into calls rather than buying protection.
Short interest is present but not the dominant story. At roughly 3.3% of the free float, it has been unwinding steadily since early April, when it peaked near 4.3%. The month-on-month decline runs to about 22% in share terms. Borrow cost has also eased sharply — down more than 52% over the week to 0.51% annually. Availability at around 118% of outstanding short interest means the lending pool is not under any stress; there are nearly 1.2 shares available to borrow for every share already short. The borrow market is not flagging any squeeze dynamic. The short score of 33.5 is consistent with that: moderate, trending lower, and well within a range that implies no acute pressure.
The valuation picture offers context for why shorts have been retreating. The P/E ratio has been compressing — down roughly 1.4 turns over the past 30 days to around 9.98x. The EV/EBITDA multiple has moved in the same direction, shedding about 0.56x over the month to 17.1x. For a specialty P&C insurer trading at a price-to-book of 0.26x, the market has been discounting the name heavily relative to book value. The Q1 beat — revenue nearly 60% above estimates — raises the question of whether those multiples are still anchored to the right earnings baseline.
Institutional ownership gives a mixed read. BlackRock holds just under 10% and Vanguard just over 5.5%, with both making incremental additions at the March quarter-end. Wolf Hill Capital Management added more than 730,000 shares as of December, and Morgan Stanley built a position of nearly 900,000 shares in the same period. On the other side, Tontine Management trimmed by 295,000 shares and Western Standard reduced by 136,000. The CEO, Claude LeBlanc, holds over 2.3% of the company and added 12,000 shares in January at $7.59 — a price well above where the stock has since traded — giving that purchase more context than it might otherwise carry. Insider activity over the 90-day window nets to roughly 26,000 shares bought after accounting for award-related selling, though the dollar figures are small.
Closest peers diverged sharply on the day. BOW jumped 7.7% and finished the week up 3.0%, while CNA fell 8.6% for the week — suggesting idiosyncratic moves rather than a sector-wide tide. TRV and PGR both slipped about 2.6-2.8% over the week, keeping them broadly in line with OSG's own 4.2% pullback.
The Q1 2026 earnings call on May 7 is now the lens through which all of this data will be reassessed — how management frames the revenue run rate, whether the book-value discount is structural or temporary, and whether the option market's bullish pre-earnings lean finds any vindication in guidance.
See the live data behind this article on ORTEX.
Open OSG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
